featured
Increased Risk of VTE With DPP-4 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
DPP-4 Inhibitors and Venous Thromboembolism: An Analysis of the WHO Spontaneous Reporting database
Lancet Diabetes Endocrinol 2020 May 01;8(5)365-367, A Gouverneur, A Lair, M Arnaud, B Bégaud, E Raschi, A Pariente, F SalvoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.